• Users Online: 294
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Contacts Login 

    Article Cited by others


Overview of clinical trials for dry age-related macular degeneration

Cheng Wen-Sheng, Lu Da-Wen, Chiang Chiao-Hsi, Chang Charn-Jung

Year : 2017| Volume: 37| Issue : 4 | Page no: 121-129

   This article has been cited by
1 Age-Related Macular Degeneration: What Do We Know So Far?
Ho Hin Ma,Rasa Liutkeviciene
Acta medica Lituanica. 2021; 28(1): 7
[Pubmed]  [Google Scholar] [DOI]
2 Intracellular amyloid- disrupts tight junctions of retinal pigment epithelium via NF-?B activation
Dong Hyun Jo,Chang Sik Cho,Jin Hyoung Kim,Jeong Hun Kim
Neurobiology of Aging. 2020;
[Pubmed]  [Google Scholar] [DOI]
3 Ocular Disease Therapeutics: Design and Delivery of Drugs for Diseases of the Eye
Kuei-Ju Cheng,Chien-Ming Hsieh,Kunal Nepali,Jing-Ping Liou
Journal of Medicinal Chemistry. 2020;
[Pubmed]  [Google Scholar] [DOI]
4 Fundamental differences in patterns of retinal ageing between primates and mice
Jaimie Hoh Kam,Tobias W. Weinrich,Harpreet Shinhmar,Michael B. Powner,Nicholas W. Roberts,Asmaa Aboelnour,Glen Jeffery
Scientific Reports. 2019; 9(1)
[Pubmed]  [Google Scholar] [DOI]
5 Therapeutic Approaches with Intravitreal Injections in Geographic Atrophy Secondary to Age-Related Macular Degeneration: Current Drugs and Potential Molecules
Marcella Nebbioso,Alessandro Lambiase,Alberto Cerini,Paolo Giuseppe Limoli,Maurizio La Cava,Antonio Greco
International Journal of Molecular Sciences. 2019; 20(7): 1693
[Pubmed]  [Google Scholar] [DOI]
6 Retinal pigment epithelial cells as a therapeutic tool and target against retinopathies
Barbara Pavan,Alessandro Dalpiaz
Drug Discovery Today. 2018;
[Pubmed]  [Google Scholar] [DOI]


Read this article